Sean Flynn

Sean Flynn

How the Leaked TPP ISDS Chapter Threatens Intellectual Property Limitations and Exceptions

I released a statement earlier today opining that the today’s leak of the Investor State Dispute Settlement (ISDS) chapter proposed for the Trans Pacific Partnership (TPP) agreement (available at ) would give new rights to private companies to challenge limitations…

How the Leaked TPP ISDS Chapter Threatens Intellectual Property Limitations and Exceptions

I released a statement earlier today opining that the today’s leak of the Investor State Dispute Settlement (ISDS) chapter proposed for the Trans Pacific Partnership (TPP) agreement (available at ) would give new rights to private companies to challenge limitations…

Statement: Leaked TPP ISDS Chapter Threatens Intellectual Property Limitations and Exceptions

Today’s leak of the Investor State Dispute Settlement (ISDS) chapter proposed for the Trans Pacific Partnership (TPP) agreement would give new rights to private companies to challenge limitations and exceptions to copyrights, patents, and other intellectual property rights in unaccountable…

Responding to Frequently Asked Questions: TPP TTIP Pharmaceutical Reimbursement “Transparency”

Brand name pharmaceutical companies are advocating for inclusion of disciplines on public pharmaceutical reimbursement programs in the ongoing negotiations of the Trans-Pacific Partnership agreement (TPP) and the Transatlantic Trade and Investment Partnership (TTIP) trade agreements. This post answers some frequently asked questions…